Financials

  • Market Capitalization 2.37 B
  • Employee 124
  • Founded 2005
  • CEO N/A
  • Website www.kodiak.com
  • Headquarter Delaware, United States
  • FIGI BBG00BVR0D02
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-9.3
Relación precio/flujo de caja
378.12

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
1865
VERA
Vera Therapeutics, Inc. - Class A Common Stock
34.19 USD-1.18%+6.02%+7.45%+14.96%2.46 B USD
1880
TRVI
Trevi Therapeutics, Inc. - Common Stock
16.79 USD-6.51%-4.60%-8.40%+134.83%2.39 B USD
1895
NUVB
Nuvation Bio Inc. Class A Common Stock
6.67 USD-4.71%-2.20%+6.38%+127.65%2.34 B USD
1901
BHVN
Biohaven Ltd. Common Shares
15.40 USD-4.47%+10.39%+13.32%-9.10%2.33 B USD

Noticias